Lv3
220 积分 2025-10-03 加入
Comparison of Obinutuzumab and Rituximab for Treating Primary Membranous Nephropathy
14天前
已完结
Targeted therapeutic options based on the pathogenesis of IgA nephropathy
3个月前
已完结
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
3个月前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
3个月前
已完结
What do clinical trials teach us about the pathophysiology of human IgA nephropathy?
5个月前
已关闭
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
6个月前
已完结
IgA Nephropathy: Core Curriculum 2021
6个月前
已完结
皖公网安备34019202002308
